(Q35116765)

6 August 2017

1 reference

title

PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma (English)

1 reference

emission computed tomography

6 August 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12719922

28 December 2023

1

Christiaan Schiepers

0 references

author name string

Jean-Emmanuel Filmont

series ordinal

2

1 reference

6 August 2017

Johannes Czernin

series ordinal

3

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12719922

28 December 2023

publication date

26 April 2003

1 reference

full work available at URL

6 August 2017

http://link.springer.com/content/pdf/10.1007/s00259-003-1165-6.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00259-003-1165-6

http://link.springer.com/article/10.1007/s00259-003-1165-6/fulltext.html

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00259-003-1165-6

http://link.springer.com/content/pdf/10.1007/s00259-003-1165-6

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00259-003-1165-6

European Journal of Nuclear Medicine and Molecular Imaging

28 December 2023

published in

1 reference

6 August 2017

volume

30 Suppl 1

1 reference

6 August 2017

page(s)

S82-8

1 reference

Ga-67 SPECT before and after treatment of lymphoma

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-003-1165-6

The role of gallium-67 in the clinical evaluation of cancer

21 January 2018

1 reference

12 December 2020

Comparison of MR imaging and CT in discriminating tumor infiltration of bone and bone marrow in the skull base

1 reference

12 December 2020

Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy

1 reference

12 December 2020

Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

12 December 2020

Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma

1 reference

12 December 2020

FDG-PET for predicting the prognosis of malignant lymphoma

1 reference

12 December 2020

Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity

1 reference

12 December 2020

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

1 reference

12 December 2020

Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

12 December 2020

Cancer statistics, 2002

1 reference

12 December 2020

Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).

1 reference

12 December 2020

Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL.

1 reference

12 December 2020

F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease

1 reference

12 December 2020

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow

1 reference

12 December 2020

2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial

1 reference

12 December 2020

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).

1 reference

12 December 2020

Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma

1 reference

12 December 2020

FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma

1 reference

12 December 2020

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

12 December 2020

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma

1 reference

12 December 2020

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT

1 reference

12 December 2020

Extranodal malignant lymphoma: detection with FDG PET versus CT

1 reference

12 December 2020

Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography

1 reference

12 December 2020

Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma

1 reference

12 December 2020

Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma

1 reference

12 December 2020

Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma

1 reference

12 December 2020

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution

1 reference

12 December 2020

Present state and future role of gallium-67 scintigraphy in lymphoma.

1 reference

12 December 2020

Cross-sectional imaging with CT and/or MRI of pediatric chest tumors.

1 reference

12 December 2020

The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging

1 reference

12 December 2020

The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients

1 reference

12 December 2020

Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study

1 reference

12 December 2020

Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.

1 reference

12 December 2020

PET in oncology: will it replace the other modalities?

1 reference

12 December 2020

Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose

1 reference

12 December 2020

Detection of lymphoma in bone marrow by whole-body positron emission tomography

1 reference

12 December 2020

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

12 December 2020

The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis

1 reference

12 December 2020

Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease

1 reference

12 December 2020

Acta radiologica. Supplementum

17

417

1

Rodriguez

1998

1 reference

https://api.crossref.org/works/10.1007/S00259-003-1165-6

28 December 2023

35

86

266

Jerusalem

2001

1 reference

https://api.crossref.org/works/10.1007/S00259-003-1165-6

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference